Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 88, Issue 3, 2003, Pages

  Ng, P C ^a   Li, K ^a   Wong, R P O ^a   Chui, K ^a   Wong, E ^a   Li, G ^a   Fok, T F ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; DISEASE COURSE; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDY; REGULATORY MECHANISM; SEPSIS;

EID: 0037542501     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.88.3.f209     Document Type: Article

References (26)

1. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000;85:9-21.
2. Zimmer S, Pollard V, Marshall GD, et al. Effects of endotoxin on the Th1/Th2 response in humans. Journal of Burns Care Rehabilitation 1996;17:491-6.
3. van Dissel JT, van Langevelde P, Westendorp RGJ, et al. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998;351:950-3.
4. Marchant A, Deviére J, Byl B, et al. Interleukin-10 production during septicaemia. Lancet 1994;343:707-8.
5. Kasai T, Inada K, Takakuwa T, et al. Anti-inflammatory cytokine levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 1997;98:34-42.
6. Taniguchi T, Koido Y, Aiboshi J, et al. Change in the ratio of intedeukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 1999;27:1262-4.
7. Pinsky MR, Vincent JL, Deviére J, et al. Serum cytokine levels in human septic shock: relation to multiple-system organ failure and mortality. Chest 1993;103:565-75.
8. Marty C, Misset B, Tamion F, et al. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin. Crit Care Med 1994;22:673-9.
9. Gerard C, Bruyns C, Marchant A, et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 1993;177:547-50.
10. Howard M, Muchamuel T, Andrade S, et al. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993;177:1205-8.
11. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome and the multiple organ dysfunction syndrome. Ann Intern Med 1996;125:690-1.
12. Fisher CJ, Agosti JM, Opal SM, et al. Treatment of septic shock with the tumour necrosis factor: Fc fusion protein. N Engl J Med 1996;334:1697-702.
13. Mosmann TR. Cytokine secretion patterns and cross regulation of T cell subsets. Immunol Res 1991;10:183-8.
14. Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
15. Rook GA, Hernandez-Pando R, Lightman SL. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994;15:301-3.
16. Stern CM. Neonatal infection: neonatal immunology (Part 1). In: Roberton NRC, ed. Textbook of neonatology. 2nd ed. Edinburgh: Churchill Livingstone, 1992:925-41.
17. Ng PC, Cheng SH, Chui KM, et al. Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecules, and C reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1997;77:F221-7.
18. Calanda T, Baumgartner JD, Grav GE, et al. The Swiss-Dutch J5 Immunoglobulin Study Group. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, and interferon-α, and interferon-γ in the serum of patients with septic shock. J Infect Dis 1990;16:982-7.
19. Cannon JG, Tompkins RG, Gelfand JA, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990;161:79-84.
20. van der Poll T, Jansen J, Levi M, et al. Regulation of interleukin-10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 1994;180:1985-8.
21. Cassatella MA, Meda L, Bonora S, et al. Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207-11.
22. Fiorentino DF, Zlotnik A, Mosmann TR, et al. Interleukin-10 (IL-10) inhibits cytokines by activated monocytes. J Immunol 1991;147:385-422.
23. Marchant A, Alegre ML, Hakim A, et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 1995;15:266-73.
24. Gomez-Jimenez J, Martin MC, Sauri R, et al. Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 1995;171:472-75.
25. van der Poll T, Marchant A, Buurmon WA, et al. Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol 1995;155:5397-401.
26. Ishida H, Hastings R, Thompson-Snipes L, et al. Modified immunological status of anti-IL-10 treated mice. Cell Immunol 1993;148:371-84.